Dr Datsons Labs to sell anti-malarial drugs in Yemen

New Delhi, March 2, 2015: Dr Datsons Labs has signed a marketing and supply agreement with Yemen's Al-Mugdh Pharma. The company plans to sell anti-malarial drugs in Yemen under the agreement.


The estimated order for Yemen is to the tune of Rs 80 crore, the company said in a BSE filing. The Indian company is looking at widening its product basket to cater to regulated and semi-regulated markets.


* Indicates mandatory field.
Please wait while comments are being sent...